Hey Plough, what can you see in the near future that can move the price?
I would think that any positive news from the USA compassionate use patient would have an effect. That would be pretty compelling evidence they have the goods after putting one advanced RCC patient into long term remission already. The outlook for advanced patients in this cancer is bleak and two in a row(although not a trial) should get everybodys attention.
Still holding, although why, why, why didnt we sell at 20c and buy back at these levels.
SBP
solbec pharmaceuticals limited
